cTRL Therapeutics announces new Chief Executive Officer to continue advancing its novel immune cell therapy Posted on November 2, 2023 (March 7, 2024) by Ricky November 2, 2023 – cTRL Therapeutics (“cTRL”), a FACIT co-founded and financed company developing novel tumour cell therapies for patients living with cancer, welcomes industry veteran Derrell D. Porter, M.D., as Chief Executive Officer.